The work of Dr. Jane Roberts is currently featured on the College of Arts and Sciences website. The new article entitled Piecing together the Autism puzzle explains how our research connects the social and biological science to improve the health of children and families.
Dr. Jane Roberts participated in UC Davis’ Distinguished Lecture Series on April 12th 2017. Her talk was entitled, Biobehavioral Profiles in Infants with Fragile X Syndrome: Emergence of Autism and Anxiety in Fragile X Syndrome. She spoke about characterizing the phenotype of fragile X syndrome, the leading known single-gene cause of autism spectrum disorders. In addition, Dr. Roberts talked about her latest research which focuses on the role of anxiety in autism and their interface across the developmental spectrum.
National Fragile X Advocacy Day took place February 28th – March 1st, 2017 in Washington D.C.! Dr. Jane Roberts was proud to be able to attend this annual event along with many other influential interventionists who are fighting for the rights of the Fragile X Community! Here, Dr. Roberts is pictured with Dejan Budimirovic M.D., medical co-director of the Fragile X Clinic at Kennedy Krieger Institute, as well as Tracy Stackhouse, and Sarah (“Mouse”) Scharfenaker, the co-founders of Developmental FX in Denver Colorado. Parents, family members and self-advocates living with Fragile X are encouraged to participate in this annual event and make their voices heard!
Kenneth Kelty is amazing and inspiring. Dr. Jane Roberts was lucky to meet him at an early age and be able to see the potential in this young man. http://www.globi-observatory.org/my-journey-as-a-public-speaker-with-autism/
Dr. Jane Roberts received over 6 million dollars in funding in 2016 and for this reason, she is currently featured in the USC College of Arts and Sciences Top News Stories. The grants received from the National Institute for Mental Health fund studies which aim to determine the developmental trajectories of disorders such as Autism and Fragile X Syndrome as well as the relation between protective factors and mental health outcomes in early childhood. To read more about these projects, her community engagement and her collaborative efforts with other researchers, you may reference the full article here.
The High Risk Baby Siblings Research Consortium (BSRC) is a group consisting of 25 accomplished scientists, which represent 21 research institutions in the United States, Canada, Israel, and the United Kingdom. At their most recent meeting this October in San Diego CA, Dr. Jane Roberts presented a paper entitled: Autism Features in Infants with Fragile X. It was an honor to be a part of the collaborative effort across many research sites to discover the earliest signs of ASD, its early risk factors, and new methods for early diagnosis.
In September 2016, Dr. Jane Roberts was awarded funding by the National Institute of Mental Health for the project entitled: Emergence, Stability and Predictors of Anxiety in Fragile X Syndrome. It is the first longitudinal developmental study of the early features of anxiety in very young boys with FXS contrasted to boys diagnosed with ASD (non-FXS) and typical controls. The study analyzes the age which initial features of anxiety can be detected and the stability and prognostic value of these early symptoms. Our lab is eager to start work on this exciting new project!!
In 2011, Dr. Roberts was the recipient of a five year NIH R01 grant entitled “Emergence and Stability of Autism in Fragile X Syndrome.” In this study, Dr. Roberts and her team analyzed the behavior of infants who were at high risk for developing autism. She has now been awarded 3.1 million dollars from NIH to follow-up of these infants and track their development into their preschool years! With this new award, the team at the Neurodevelopmental Lab will be able to follow the development of the infants from 9 months-of-age to 5 years-of-age and identify which features during infancy were predictive of developmental delays in the infants at high risk for developmental impairments. This information will then be translated to efforts targeting early identification and treatment.